(Q36675105)

English

Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease

scientific article published on 28 December 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Tofacitinib, a janus kinase inhibitor demonstrates efficacy in an IL-15 transgenic mouse model that recapitulates pathologic manifestations of celiac disease (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Liyanage P Perera

5

object named as

Liyanage P Perera

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Thomas Waldmann

3

object named as

Thomas A Waldmann

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

Seiji Yokoyama

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Pin-Yu Perera

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Takachika Hiroi

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

publication date

28 December 2012

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Journal of Clinical Immunology

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

33

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

586-594

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Kinase inhibitors in the treatment of immune-mediated disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

30 September 2017

Novel small-molecular therapeutics for rheumatoid arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

30 September 2017

How I treat enteropathy-associated T-cell lymphoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

30 September 2017

Update on celiac disease - etiology, differential diagnosis, drug targets, and management advances

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

30 September 2017

The role of interleukin-15 in inflammation and immune responses to infection: implications for its therapeutic use

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

30 September 2017

Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

30 September 2017

Integration of genetic and immunological insights into a model of celiac disease pathogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

30 September 2017

Enteropathy-associated T-cell lymphoma: a review on clinical presentation, diagnosis, therapeutic strategies and perspectives.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

30 September 2017

IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

30 September 2017

Antibody-mediated blockade of IL-15 reverses the autoimmune intestinal damage in transgenic mice that overexpress IL-15 in enterocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

30 September 2017

The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

30 September 2017

The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

30 September 2017

IL-15 interferes with suppressive activity of intestinal regulatory T cells expanded in Celiac disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

5 September 2018

A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

5 September 2018

Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594487

5 September 2018

Inhibition of TGF-β Signaling by IL-15: A New Role for IL-15 in the Loss of Immune Homeostasis in Celiac Disease

1 reference

https://api.crossref.org/works/10.1007%2FS10875-012-9849-Y

21 January 2018

Advances in coeliac disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23269601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transgenic mice that overexpress human IL-15 in enterocytes recapitulate both B and T cell-mediated pathologic manifestations of celiac disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23269601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pfizer's JAK inhibitor sails through phase 3 in rheumatoid arthritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/23269601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

IL-15-dependent activation-induced cell death-resistant Th1 type CD8 alpha beta+NK1.1+ T cells for the development of small intestinal inflammation

1 reference

https://pubmed.ncbi.nlm.nih.gov/23269601

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10875-012-9849-Y

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

release_7m5pwyheqbfu3eoo4ieau4rxtq

1 reference

https://api.fatcat.wiki/v0/release/7m5pwyheqbfu3eoo4ieau4rxtq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36675105&oldid=2199171551"